Keyphrases
Normal Human
100%
Integrin
100%
Human Osteosarcoma Cells
100%
Days of Treatment
37%
Dexamethasone Treatment
37%
Osteopontin
37%
Vitronectin
37%
Adhesion
25%
Cell Adhesion
25%
Promoter Activity
25%
Post-transcriptional Events
25%
Prolonged Exposure
12%
MRNA Level
12%
Cell-matrix Interactions
12%
Matrix Protein
12%
Bone Formation
12%
Pharmacological Dose
12%
MRNA Stability
12%
Integrin Expression
12%
Detrimental Effects
12%
Five-level
12%
Early-life Exposure
12%
Osteoporosis
12%
Matrix Interaction
12%
Labeling Experiment
12%
Osteoblast Functions
12%
Metabolic Labeling
12%
Ligand Specificity
12%
Long-term Exposure
12%
Short-term Exposure
12%
Bone Matrix Proteins
12%
Long-term Administration
12%
Surface Adhesion
12%
Biphasic Regulation
12%
Biochemistry, Genetics and Molecular Biology
Dexamethasone
100%
Normal Human
100%
Integrin
100%
Messenger RNA
16%
Osteopontin
16%
Vitronectin
16%
Anabolism
11%
Glucocorticoid
11%
Matrix Protein
11%
Surface Property
11%
Promoter Region
11%
Cell Adhesion
11%
Ossification
5%
Osteoblast
5%
Transcription
5%
mRNA Stability
5%
Pharmacology, Toxicology and Pharmaceutical Science
Dexamethasone
100%
Normal Human
100%
Integrin
100%
Osteopontin
16%
Vitronectin
16%
Glucocorticoid
11%
Long Term Exposure
11%
Matrix Protein
11%
Neuroscience
Integrin
100%
Dexamethasone
100%
Vitronectin
16%
Osteopontin
16%
Anabolism
11%
Promoter Region
11%
Cell Adhesion
11%
Matrix Protein
11%
Glucocorticoid
11%
Extracellular Matrix
5%